Diagnostic performance of a seven-marker serum protein biosignature for the diagnosis of active TB disease in African primary healthcare clinic attendees with signs and symptoms suggestive of TB

Thorax

Volumn 71, Issue 9, 2016, Pages 785-794

  Chegou, Novel N ^a   Sutherland, Jayne S ^b   Malherbe, Stephanus ^a   Crampin, Amelia C ^c   Corstjens, Paul L A M ^d   Geluk, Annemieke ^d   Mayanja Kizza, Harriet ^e   Loxton, Andre G ^a   Van Der Spuy, Gian ^a   Stanley, Kim ^a   Kotzé, Leigh A ^a   Van Der Vyver, Marieta ^f   Rosenkrands, Ida ^g   Kidd, Martin ^h   Van Helden, Paul D ^a   Dockrell, Hazel M ⁱ   Ottenhoff, Tom H M ^d   Kaufmann, Stefan H E ^j   Walzl, Gerhard ^a  

^a UNIVERSITY OF STELLENBOSCH   (South Africa)

^b Medical Research Council Unit   (Gambia)

^c KARONGA PREVENTION STUDY   (Malawi)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^e MAKERERE UNIVERSITY   (Uganda)

^f UNIVERSITY OF NAMIBIA   (Namibia)

^g STATENS SERUM INSTITUT   (Denmark)

^h STELLENBOSCH UNIVERSITY   (South Africa)

ⁱ LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^j MAX PLANCK INSTITUTE FOR INFECTION BIOLOGY   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 MACROGLOBULIN; ALPHA2 INTERFERON; APOLIPOPROTEIN A1; APOLIPOPROTEIN C3; C REACTIVE PROTEIN; COMPLEMENT FACTOR H; FERRITIN; FIBRINOGEN; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GELATINASE A; GELATINASE B; HAPTOGLOBIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; PREALBUMIN; PROCALCITONIN; SERUM AMYLOID A; SERUM AMYLOID P; TISSUE PLASMINOGEN ACTIVATOR; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR NECROSIS FACTOR; VASCULOTROPIN; BIOLOGICAL MARKER; PLASMA PROTEIN;

ADULT; AFRICA; ALGORITHM; ARTICLE; BLOOD SAMPLING; CLINICAL ASSESSMENT; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE CLASSIFICATION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LABORATORY TEST; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIMARY HEALTH CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY; THORAX RADIOGRAPHY; AIDS-RELATED OPPORTUNISTIC INFECTIONS; BLOOD; CLINICAL TRIAL; MIDDLE AGED; MULTICENTER STUDY; POINT OF CARE SYSTEM; TUBERCULOSIS, PULMONARY;

ADULT; AFRICA; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ALGORITHMS; BIOMARKERS; BLOOD PROTEINS; FEMALE; HUMANS; MALE; MIDDLE AGED; POINT-OF-CARE SYSTEMS; PREDICTIVE VALUE OF TESTS; PRIMARY HEALTH CARE; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS, PULMONARY;

EID: 84966415358     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2015-207999     Document Type: Article

References (40)

1. World Health Organisation. Global Tuberculosis Report. 2015.
2. Chegou NN, Hoek KG, Kriel M, et al. Tuberculosis assays: past, present and future. Expert Rev Anti Infect Ther 2011;9:457-69.
3. Trébucq A, Enarson DA, Chiang CY, et al. Xpert((R)) MTB/RIF for national tuberculosis programmes in low-income countries: when, where and how? Int J Tuberc Lung Dis 2011;15:1567-72.
4. Marais BJ, Pai M. New approaches and emerging technologies in the diagnosis of childhood tuberculosis. Paediatr Respir Rev 2007;8:124-33.
5. Chegou NN, Walzl G, Bolliger CT, et al. Evaluation of adapted whole-blood interferon-gamma release assays for the diagnosis of pleural tuberculosis. Respiration 2008;76:131-8.
6. Phalane KG, Kriel M, Loxton AG, et al. Differential expression of host biomarkers in saliva and serum samples from individuals with suspected pulmonary tuberculosis. Mediators Inflamm 2013;2013:981984.
7. Chegou NN, Black GF, Loxton AG, et al. Potential of novel Mycobacterium tuberculosis infection phase-dependent antigens in the diagnosis of TB disease in a high burden setting. BMC Infect Dis 2012;12:10.
8. Essone PN, Chegou NN, Loxton AG, et al. Host cytokine responses induced after overnight stimulation with novel M. tuberculosis infection phase-dependent antigens show promise as diagnostic candidates for TB disease. PLoS ONE 2014;9:e102584.
9. Goletti D, Vincenti D, Carrara S, et al. Selected RD1 peptides for active tuberculosis diagnosis: comparison of a gamma interferon whole-blood enzyme-linked immunosorbent assay and an enzyme-linked immunospot assay. Clin Diagn Lab Immunol 2005;12:1311-16.
10. Chegou NN, Black GF, Kidd M, et al. Host markers in Quantiferon supernatants differentiate active TB from latent TB infection: preliminary report. BMC Pulm Med 2009;9:21.
11. Chegou NN, Essone PN, Loxton AG, et al. Potential of host markers produced by infection phase-dependent antigen-stimulated cells for the diagnosis of tuberculosis in a highly endemic area. PLoS ONE 2012;7:e38501.
12. Chegou NN, Detjen AK, Thiart L, et al. Utility of host markers detected in quantiferon supernatants for the diagnosis of tuberculosis in children in a high-burden setting. PLoS ONE 2013;8:e64226.
13. Frahm M, Goswami ND, Owzar K, et al. Discriminating between latent and active tuberculosis with multiple biomarker responses. Tuberculosis (Edinb) 2011;91:250-6.
14. Kellar KL, Gehrke J, Weis SE, et al. Multiple cytokines are released when blood from patients with tuberculosis is stimulated with Mycobacterium tuberculosis antigens. PLoS ONE 2011;6:e26545.
15. Baumann R, Kaempfer S, Chegou NN, et al. Serologic diagnosis of tuberculosis by combining Ig classes against selected mycobacterial targets. J Infect 2014;69:581-9.
16. Baumann R, Kaempfer S, Chegou NN, et al. A Subgroup of Latently Mycobacterium tuberculosis Infected Individuals Is Characterized by Consistently Elevated IgA Responses to Several Mycobacterial Antigens. Mediators Inflamm 2015;2015:364758.
17. Chegou NN, Heyckendorf J, Walzl G, et al. Beyond the IFN-gamma horizon: biomarkers for immunodiagnosis of infection with Mycobacterium tuberculosis. Eur Respir J 2014;43:1472-86.
18. Claassens MM, du Toit E, Dunbar R, et al. Tuberculosis patients in primary care do not start treatment. What role do health system delays play? Int J Tuberc Lung Dis 2013;17:603-7.
19. Fluss R, Faraggi D, Reiser B. Estimation of the youden index and its associated cutoff point. Biom J 2005;47:458-72.
20. Statsoft. General Discriminant Analysis (GDA). Statsoft Electronic Statistics Textbook. http://www.statsoft.com/textbook/general-discriminant-analysis/button/1 (accessed 7 Jan 2016).
21. Breiman L. Random forests. Mach Learn 2001;45:5-32.
22. Black S, Kushner I, Samols D. C reactive protein. J Biol Chem 2004;279:48487-90.
23. de Beer FC, Nel AE, Gie RP, et al. Serum amyloid A protein and C-reactive protein levels in pulmonary tuberculosis: relationship to amyloidosis. Thorax 1984;39:196-200.
24. Kotru M, Rusia U, Sikka M, et al. Evaluation of serum ferritin in screening for iron deficiency in tuberculosis. Ann Hematol 2004;83:95-100.
25. Pandey R, Rodriguez GM. A ferritin mutant of Mycobacterium tuberculosis is highly susceptible to killing by antibiotics and is unable to establish a chronic infection in mice. Infect Immun 2012;80:3650-9.
26. Opolot JO, Theron AJ, Anderson R, et al. Acute phase proteins and stress hormone responses in patients with newly diagnosed active pulmonary tuberculosis. Lung 2015;193:13-18.
27. Visser A, van de Vyver A. Severe hyperferritinemia in Mycobacteria tuberculosis infection. Clin Infect Dis 2011;52:273-4.
28. Singh M, Anand L. Bedside procalcitonin and acute care. Int J Crit Illn Inj Sci 2014;4:233-7.
29. Hoeboer SH, van der Geest PJ, Nieboer D, et al. The diagnostic accuracy of procalcitonin for bacteraemia: a systematic review and meta-analysis. Clin Microbiol Infect 2015;21:474-81.
30. Schleicher GK, Herbert V, Brink A, et al. Procalcitonin and C-reactive protein levels in HIV-positive subjects with tuberculosis and pneumonia. Eur Respir J 2005;25:688-92.
31. Montecucco F, Favari E, Norata GD, et al. Impact of systemic inflammation and autoimmune diseases on apoA-I and HDL plasma levels and functions. Handb Exp Pharmacol 2015;224:455-82.
32. Ferreira VP, Pangburn MK, Cortes C. Complement control protein factor H: the good, the bad, and the inadequate. Mol Immunol 2010;47: 2187-97.
33. Carroll MV, Lack N, Sim E, et al. Multiple routes of complement activation by Mycobacterium bovis BCG. Mol Immunol 2009;46:3367-78.
34. Buxbaum JN, Reixach N. Transthyretin: the servant of many masters. Cell Mol Life Sci 2009;66:3095-101.
35. Wang C, Li YY, Li X, et al. Serum complement C4b, fibronectin, and prolidase are associated with the pathological changes of pulmonary tuberculosis. BMC Infect Dis 2014;14:52.
36. Luo H, Zhu B, Gong L, et al. The value of serum prealbumin in the diagnosis and therapeutic response of tuberculosis: a retrospective study. PLoS ONE 2013;8: e79940.
37. Agranoff D, Fernandez-Reyes D, Papadopoulos MC, et al. Identification of diagnostic markers for tuberculosis by proteomic fingerprinting of serum. Lancet 2006;368:1012-21.
38. Corstjens PL, Chen Z, Zuiderwijk M, et al. Rapid assay format for multiplex detection of humoral immune responses to infectious disease pathogens (HIV, HCV, and TB). Ann N Y Acad Sci 2007;1098:437-45.
39. Corstjens PL, Zuiderwijk M, Tanke HJ, et al. A user-friendly, highly sensitive assay to detect the IFN-gamma secretion by T cells. Clin Biochem 2008;41:440-4.
40. Corstjens PL, Tjon Kon Fat EM, de Dood CJ, et al. Multi-center evaluation of a user-friendly lateral flow assay to determine IP-10 and CCL4 levels in blood of TB and non-TB cases in Africa. Clin Biochem 2016;49: 22-31.